TP53 and melanoma: USP5 in melanoma suppressed cell growth by reinforcing the S/G2-M checkpoint, enhancing extrinsic caspase activation through modulation of p53 and FAS levels and amplifying the apoptotic activity of kinase inhibitors [28].